Although protein glycosylation is conserved, genome sequence analysis does not reveal the actual glycan composition of a cell or tissue. Cell type, metabolic and developmental states, availability of nutrients and other variables determine the biosynthetic pathway responsible for glycoprotein production. In systems biology, the composition of glycans cannot be predicted and has to be experimentally elucidated.
- Glycoproteomics is the study of the glycans present in the repertoire of proteins expressed in a given cell, tissue, or organism.
- Glycoproteomics can also identify when a site is glycosylated (occupancy) and obtain structural and quantitative composition of each glycan.
- Glycomics studies define the total glycan composition of the system.
- Because of the complexity and variability in protein glycosylation, glycoproteomics and glycomics approaches are complementary and, when used together, can create a more complete picture of the system.
- The ultimate goal of glycomics and glycoproteomics is to obtain comparisons between species, developmental states, disease conditions, etc.
- Interpretation, data analysis, and comparative studies are facilitated by modern bioinformatic tools and databases
Essentials of Glycobiology, 3rd edition. Cold Spring Harbor Laboratory Press; 2015-2017.
O-glycan analysis of therapeutic proteins enabled by O-glycoprotease
This article from European Pharmaceutical Review describes tools that can be used for O-glycan analysis of therapeutic proteins.
- Vainauskas, S., Kirk, C.H., Petralia, L., Guthrie, E.P., McLeod, E., Bielik, A., Luebbers, A., Foster, J.M., Hokke, C.H., Rudd, P.M., Shi, X., Taron, C.H 2018. A novel broad specificity fucosidase capable of core a1-6 fucose release from N-glycans labeled with urea-linked fluorescent dyes Sci Rep. , PubMedID: 29934601, DOI: 1038/s41598-018-27797-0
- Albrecht, S., Vainauskas, S., Stöckmann, H., McManus, C., Taron, C.H. and Rudd, P.M. 2016. Comprehensive Profiling of Glycosphingolipid Glycans Using a Novel Broad Specificity Endoglycoceramidase in a High-Throughput Workflow. Anal Chem. May 3;88(9), PubMedID: 27033327, DOI:
This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB).
While NEB develops and validates its products for various applications, the use of this product may require the buyer to obtain additional third party intellectual property rights for certain applications.
For more information about commercial rights, please contact NEB's Global Business Development team at [email protected].
This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.